Clinical Trials Logo

Filter by:
NCT ID: NCT05873257 Completed - Venous Leg Ulcer Clinical Trials

Investigation of the Clinical Performance of Biatain Fiber Ag on Venous Leg Ulcers

Start date: July 31, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to test a new gelling fiber wound dressing with silver on patients with a venous leg ulcer Participants will be asked to wear the test dressing in a four weeks period (+/- 2 days) consisting of 6 study visits, and will have the dressing changed once pr. week at the research facility. The wound will be cleaned, assessed and photos will be uploaded to a digital software system.

NCT ID: NCT05870137 Completed - Emergency Medicine Clinical Trials

Assessing Mixed Reality for Emergency Medical Care Delivery in a Simulated Environment

Start date: September 17, 2021
Phase: N/A
Study type: Interventional

This study assessed the feasibility and effectiveness of using Mixed Reality (MR) through the use of HoloLens2TM technology to enhance emergency clinical care delivery in a simulated environment. This was achieved by inviting 22 resident grade doctors to complete two scenarios. Each scenario was supported either by standard care methods or Mixed reality. The participants were randomised to at the start of the scenarios to determine which support they would receive first. The main outcome was to see if there was difference in error rates. This was assessed using the ICECAP multidimensional error capture tool. Secondary outcomes included teamwork, scenario completion, stress/cognitive load, and Mixed reality device user acceptability.

NCT ID: NCT05866055 Completed - Pain Clinical Trials

A Phase 1 Dose Escalation Study of VX-973 in Healthy Adults

Start date: May 10, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of VX-973 in healthy participants.

NCT ID: NCT05858294 Completed - Clinical trials for Social Anxiety Disorder

The Safety, Acceptability and Efficacy of Alena

Start date: October 31, 2022
Phase: N/A
Study type: Interventional

The present study is a randomised controlled trial that seeks to investigate the safety, acceptability and efficacy and safety of the Alena CBT programme as a treatment for social anxiety disorder.

NCT ID: NCT05857215 Completed - Clinical trials for Inflammatory Disease

A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects

Start date: March 5, 2021
Phase: Phase 1
Study type: Interventional

This is a three-part, single Centre, double-blind, randomized, placebo-controlled first-in-human study of single ascending doses (SADs, Part 1) and multiple doses (Part 2) of amilo-5MER in healthy young adult male subjects and a single dose cohort in healthy elderly male and female subjects (Part 3)

NCT ID: NCT05856734 Completed - Obesity Clinical Trials

Weight Gain in First-year University Students

Start date: September 15, 2022
Phase:
Study type: Observational

The transition to university from secondary school comes with many changes to living arrangements, dietary and alcohol intake, physical activity, and stress. The purpose of this study is to explore weight gain in new university students in the UK under the 'Freshman15' phenomenon. This phenomenon is an expression commonly used in the United States and Canada to describe a weight gain of 15 lbs (6.8 kg) in students who transition from secondary school to university life. The research will assess to investigate the impact of lifestyle factors that predict students' weight gain during their first year at the University of Aberdeen. The study specifically focuses on how these factors vary based on their living arrangement. Also, the change in lifestyle will be explored in relation to age-matched individuals not-attending university.

NCT ID: NCT05856604 Completed - Clinical trials for Cognitive Impairment

Music Therapy for Older Adults With Cognitive Decline Living in Care Homes

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

This research aims to investigate whether the use of music-improvisation therapy for older adult participants can lead to improvements in cognitive ability levels, especially in attentional functions. Very relevant reviews highlight studies that demonstrate the effectiveness of Music Therapy training. However, only a few are based on randomised criteria and structured methodological approaches. This affects the generalizability of findings, as to whether Music Therapy interventions are effective in improving cognitive functions, mood, and quality of life of people with cognitive decline. In order to make a difference, there is a need for more studies that are structured [i] according to rigorous empirical criteria (namely involving random assignment of participants to activity groups), [ii] and that gather scientific evidence, based on both standardized cognitive tests and biomarkers (hormones: Cortisol, or stress hormone, and DHEA or aging hormone; brain signal, EEG; Physiology: Respiratory Sinus Arrhythmia). In this RCT study, the investigator investigated the effect of 4-month music therapy vs Storytelling program for older adults with cognitive decline, living in care homes.

NCT ID: NCT05854355 Completed - Physical Activity Clinical Trials

Children- Sit Less, Move More (C-SLAMM): Increasing Physical Activity and Decreasing Sedentary Behaviour in Children

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The Children Sit Less, Move More (C-SLAMM) study aims to test the feasibility and potential effect of a multi-component school and home-based pilot cluster randomized control trial on reducing sedentary behavior and increasing physical activity in children. This pilot intervention will be an 8-week two-armed cluster RCT. Individuals (children aged 7-9 years) will be the unit of analysis and schools (cluster) randomly assigned to one of two arms: (1) Physical activity and sedentary behavior (intervention arm), or (2) current practice (control arm). The design conduct and reporting of the intervention with adhere to the Consolidation Standards of Reporting Trials (CONSORT) guidelines and is guided by the Standard Protocol Items for Randomized Trials (SPIRIT) Statement.

NCT ID: NCT05849675 Completed - Cognitive Function Clinical Trials

Pitolisant Effects on Affect and Cognition Exploratory Study (PEACE Study)

PEACE
Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to investigate the effects of selective histamine 3 antagonist pitolisant on brain function and cognition in healthy individuals. The main questions it aims to answer are: 1. Does pitolisant alter functional activity in brain regions linked to reward and cognitive processing during rest or cognitive task performance? 2. Does pitolisant alter cognitive ability across a range of psychological domains, including working memory, executive functioning and emotional processing? Participants will undertake fMRI scanning in addition to a battery of tasks designed to measure cognitive and emotional processing after taking a single dose of pitolisant or placebo. Researchers will compare differences in functional activity, cognition and emotional processing across the pitolisant and placebo groups.

NCT ID: NCT05848440 Completed - Clinical trials for Non-alcoholic Steatohepatitis

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants

Start date: May 2, 2023
Phase: Phase 1
Study type: Interventional

This is a Phase I Randomised Single-blind Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants.